Dopamine agonists and valvular heart disease.
Stephens
Jeffrey W
JW
Price
David E
DE
Ionescu
Adrian
A
D000077465:Cabergoline; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D004873:Ergolines / Q000008:administration & dosage / Q000009:adverse effects*; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D020257:Ventricular Remodeling / Q000187:drug effects
D018491:Dopamine Agonists; D004873:Ergolines; D000077465:Cabergoline